From Nasdaq: 2024-11-07 07:40:00

Stocks in focus this week include Alibaba Group, Pfizer, Virtu Financial, Leidos, and Brinker International. Amid election-week volatility, investors anticipate increased market turbulence with Trump’s unofficial White House return. A hybrid investment strategy blending value and growth principles could mitigate risk. The PEG ratio, a key metric in GARP investing, factors in future earnings growth to identify undervalued stocks with growth potential. Not without limitations, the PEG ratio neglects changing growth rates, prompting the need for additional parameters in investment decisions.

Among the GARP stocks highlighted, Alibaba stands out with a Zacks Rank #1, a Value Score of A, and a robust long-term growth rate of 26.5%. Pfizer’s diverse drug portfolio and operational revenue growth position it favorably with a Zacks Rank #2, Value Score of A, and a long-term growth rate of 10.7%. Virtu Financial, a market-leading financial services firm, boasts a 23.6% growth rate, a Value Score of A, and a Zacks Rank #1. Leidos, a global science and technology leader, excels with a Zacks Rank #1, a Value Score of B, and a 12.5% long-term growth rate. Brinker International, owner of popular restaurant brands, earns a Zacks Rank #1, a Value Score of B, and a solid long-term expected growth rate of 16.4%.

Nuclear energy presents a lucrative investment opportunity, with world leaders pledging to triple nuclear energy capacities. An urgent report, “Atomic Opportunity: Nuclear Energy’s Comeback,” identifies key players and technologies in the nuclear sector, including three standout stocks poised for growth. For investors seeking high-potential stocks, Zacks Investment Research offers a free report on 5 Stocks Set to Double.



Read more at Nasdaq: Zacks.com featured highlights include Alibaba Group, Pfizer, Virtu Financial, Leidos and Brinker International